In a clinical trial of patients treated with simvastatin 80 mgday, patients 65 years of age had an increased risk of myopathy, including rhabdomyolysis, compared to patients. The increased incidence of thyroid neoplasms appears to be consistent with findings from other statins. A second two-year rat carcinogenicity study with doses of 50 and 100 mgkgday produced hepatocellular adenomas and carcinomas (in female rats at both doses and in males at 100 mgkgday).
In patients at high risk of coronary events because of existing coronary heart disease, diabetes, peripheral vessel disease, history of stroke or other cerebrovascular disease, zocor is indicated to reduce the need for coronary and non-coronary revascularization procedures. In two clinical studies, one in normal volunteers and the other in hypercholesterolemic patients, simvastatin 20-40 mgday modestly potentiated the effect of coumarin anticoagulants the (inr), increased from a baseline of 1. Adolescent females should be counseled on appropriate contraceptive methods while on simvastatin therapy see.
The prices we show are our best estimate while we believe our data to be generally accurate, we cannot guarantee that the price we display will exactly match the price you receive at the pharmacy. Therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia. You may be able to lower your total cost by filling a greater quantity at one time.
Uln, over the course of the study, was not significantly different between the simvastatin and placebo groups (14 0. Lft elevations to 3x uln andor were discontinued due to transaminase elevations during the 5. However, the study was only able to exclude a 3- to 4-fold increased risk of congenital anomalies over the background rate.
Zocor therapy should also be temporarily withheld in any patient experiencing an acute or serious condition predisposing to the development of renal failure secondary to rhabdomyolysis, e. The combined use of simvastatin with gemfibrozil, cyclosporine, or danazol is contraindicated see caution should be used when prescribing other fibrates with simvastatin, as these agents can cause myopathy when given alone and the risk is increased when they are coadministered see cases of myopathy, including rhabdomyolysis, have been reported with simvastatin coadministered with colchicine, and caution should be exercised when prescribing simvastatin with colchicine see the benefits of the combined use of simvastatin with the following drugs should be carefully weighed against the potential risks of combinations other lipid-lowering drugs (other fibrates, 1 gday of niacin, or, for patients with hofh, lomitapide), amiodarone, dronedarone, verapamil, diltiazem, amlodipine, or ranolazine see cases of myopathy, including rhabdomyolysis, have been observed with simvastatin coadministered with lipid-modifying doses (1 gday niacin) of niacin-containing products. These changes appeared soon after initiation of therapy with simvastatin, were often transient, were not accompanied by any symptoms and did not require interruption of treatment.
In a two-year study in rats at 25 mgkgday, there was a statistically significant increase in the incidence of follicular adenomas in female rats exposed to approximately 11 times higher levels of simvastatin than in humans given 80 mg simvastatin (as measured by auc). It is unknown if the risk for myopathy with coadministration of simvastatin with lipid-modifying doses of niacin-containing products observed in chinese patients applies to other asian patients see prescribing recommendations for interacting agents are summarized in table 1 see also table 1 drug interactions associated with increased risk of myopathyrhabdomyolysis for patients with hofh who have been taking 80 mg simvastatin chronically (e. Liver dysfunction there have been rare reports of immune-mediated necrotizing myopathy (imnm), an muscle weakness and elevated serum creatine kinase, which persist despite discontinuation of statin treatment showing necrotizing myopathy without significant inflammation improvement with all patients starting therapy with zocor, or whose dose of zocor is being increased, should be advised of the risk of myopathy, including rhabdomyolysis, and told to report promptly any unexplained muscle pain, tenderness or weakness particularly if accompanied by malaise or fever or if muscle signs and symptoms persist after discontinuing zocor. All trademarks, brands, logos and copyright images are property of their respective owners and rights holders and are used solely to represent the products of these rights holders. If serious liver injury with clinical symptoms andor or jaundice occurs during treatment with zocor, promptly interrupt therapy.
This enzyme catalyzes the conversion of hmg-coa to mevalonate, which is an early and rate-limiting step in the biosynthesis of cholesterol. Goodrx is not sponsored by or affiliated with any of the pharmacies identified in its price comparisons. If zocor is used during pregnancy or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to the fetus. In rare cases, simvastatin can cause a condition that results in the breakdown of skeletal muscle tissue, leading to kidney failure. In patients at high risk of coronary events because of existing coronary heart disease, diabetes, peripheral vessel disease, history of stroke or other cerebrovascular disease, zocor is indicated to reduce the need for coronary and non-coronary revascularization procedures.
Because a small amount of another drug in this class is excreted in human milk and because of the potential for serious adverse reactions in nursing infants, women taking simvastatin should not nurse their infants. All of the patients in this study received a starting dose of 20 mg of simvastatin 37 were titrated to 40 mg. Goodrx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. The risk of myopathy is increased by elevated plasma levels of simvastatin and simvastatin acid. In such patients, prothrombin time should be determined before starting simvastatin and frequently enough during early therapy to ensure that no significant alteration of prothrombin time occurs.
This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. After oral ingestion, simvastatin, which is an inactive lactone, is hydrolyzed to the corresponding -hydroxyacid form. . If serious liver injury with clinical symptoms andor or jaundice occurs during treatment with zocor, promptly interrupt therapy. In a two-year study in rats at 25 mgkgday, there was a statistically significant increase in the incidence of follicular adenomas in female rats exposed to approximately 11 times higher levels of simvastatin than in humans given 80 mg simvastatin (as measured by auc). The reports are generally nonserious, and reversible upon statin discontinuation, with variable times to symptom onset (1 day to years) and symptom simvastatin, like several other inhibitors of hmg-coa reductase, is a substrate of cyp3a4. Myopathy sometimes takes the form of rhabdomyolysis with or without secondary to myoglobinuria, and rare fatalities have occurred. Moderate (less than 3x uln) elevations of serum transaminases have been reported following therapy with simvastatin. Predisposing factors for myopathy include advanced age (65 years), female gender, uncontrolled in a clinical trial database in which 41,413 patients were treated with zocor, 24,747 (approximately 60) of whom were enrolled in studies with a median follow-up of at least 4 years, the incidence of myopathy was approximately 0. Thyroid follicular cell adenomas were increased in males and females at both doses thyroid follicular cell carcinomas were increased in females at 100 mgkgday.Find medication information including related drug classes, side effects, patient statistics and ... Simvastatin 40mg Tab ... Pill Identification: 7155,TV | 7155,93.